
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="retraction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30596791</article-id><article-id pub-id-type="pmc">6312328</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0210344</article-id><article-id pub-id-type="publisher-id">PONE-D-18-36588</article-id><article-categories><subj-group subj-group-type="heading"><subject>Retraction</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Biological Cultures</subject><subj-group><subject>Cell Cultures</subject><subj-group><subject>Cultured Tumor Cells</subject><subj-group><subject>Melanoma Cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Rheumatology</subject></subj-group></subj-group></article-categories><title-group><article-title>Retraction: Silymarin Targets &#x003b2;-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><collab>The <italic>PLOS ONE</italic> Editors</collab></contrib></contrib-group><pub-date pub-type="epub"><day>31</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>12</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>13</volume><issue>12</issue><elocation-id>e0210344</elocation-id><permissions><copyright-statement>&#x000a9; 2018 The PLOS ONE Editors</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>The PLOS ONE Editors</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0210344.pdf"/><related-article id="d35e89" related-article-type="retracted-article" ext-link-type="doi" xlink:href="10.1371/journal.pone.0023000">
<article-title>Silymarin Targets &#x003b2;-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells</article-title>
</related-article><counts><fig-count count="0"/><table-count count="0"/><page-count count="1"/></counts></article-meta></front><body><p>Following publication of this article [<xref rid="pone.0210344.ref001" ref-type="bibr">1</xref>], concerns were raised regarding Figure 5E. An area in the bottom right quadrant of the second panel (silymarin 10&#x003bc;g/ml) is very similar to an area in the upper left quadrant of the fourth panel (silymarin 40&#x003bc;g/ml). The University of Alabama at Birmingham confirmed that the original records and data needed to determine the validity of these experiments are not available.</p><p>Following a joint investigation by the Birmingham VA Medical Center and the University of Alabama at Birmingham, the institutions requested retraction of this article, as the conclusions could not be supported by available data. In line with the institutions&#x02019; investigation and recommendation, the <italic>PLOS ONE</italic> Editors retract this article based upon the unavailability of original data and records and the ambiguous identification of samples and treatments.</p><p>The authors did not comment on the retraction decision.</p></body><back><ref-list><title>Reference</title><ref id="pone.0210344.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Vaid</surname><given-names>M</given-names></name>, <name><surname>Prasad</surname><given-names>R</given-names></name>, <name><surname>Sun</surname><given-names>Q</given-names></name>, <name><surname>Katiyar</surname><given-names>SK</given-names></name> (<year>2011</year>) <article-title>Silymarin Targets &#x003b2;-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells</article-title>. <source>PLoS ONE</source>
<volume>6</volume>(<issue>7</issue>): <fpage>e23000</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0023000</pub-id>
<pub-id pub-id-type="pmid">21829575</pub-id></mixed-citation></ref></ref-list></back></article>